Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Parallel Group, Active- and Placebo-Controlled Study to Assess the Efficacy and Safety of JNJ26489112 in Adult Subjects With Treatment-Resistant Major Depressive Disorder
Conditions
Interventions
Venlafaxine XR
Placebo
+1 more
Locations
14
United States
Arcadia, California, United States
Escondido, California, United States
San Diego, California, United States
Hartford, Connecticut, United States
Atlanta, Georgia, United States
Naperville, Illinois, United States
Start Date
March 1, 2011
Primary Completion Date
January 1, 2012
Completion Date
February 1, 2012
Last Updated
April 29, 2025
NCT05883540
NCT07538427
NCT07032363
NCT04940585
NCT06731621
NCT07360600
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions